Trials / Sponsors / Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc.
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma | Phase 2 / Phase 3 | 2025-08-06 |
| Recruiting | Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab Solid Tumor, Adult | Phase 1 / Phase 2 | 2019-10-21 |